Hepatitis C care located within a needle and syringe programme in New York achieved a three times higher cure rate than referral to a patient navigator and linkage to medical care at a harm reduction programme or clinic, a randomised trial in New York City has found.
Improving the uptake of hepatitis C care among people who inject drugs is essential for achieving the elimination of hepatitis C, especially in countries where the majority of people with hepatitis C are current drug users.
Read the full story at infohep.
Source : infohep
Related HIV and Co-Infections News
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.